Format

Send to

Choose Destination
Neurology. 2017 Sep 12;89(11):1098-1100. doi: 10.1212/WNL.0000000000004381. Epub 2017 Aug 23.

Can immune reprogramming with alemtuzumab induce permanent remission in multiple sclerosis?

Author information

1
From the Department of Neurology (H.W.), University of Muenster, Germany; Department of Neurology (D.B.), Oregon Health & Science University, Portland; and Department of Neuroinflammation (O.C.), UCL Institute of Neurology, University College London, UK. heinz.wiendl@ukmuenster.de.
2
From the Department of Neurology (H.W.), University of Muenster, Germany; Department of Neurology (D.B.), Oregon Health & Science University, Portland; and Department of Neuroinflammation (O.C.), UCL Institute of Neurology, University College London, UK.
PMID:
28835406
DOI:
10.1212/WNL.0000000000004381
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for HighWire
Loading ...
Support Center